©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113429
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113429
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113429
Table 1 Demographic and clinical characteristics of patients undergoing radiofrequency ablation, n (%)/mean ± SD
| Variable | Groups | All patients |
| Age (years) | 60.879 ± 9.03 | |
| Gender | Male | 68 (74.73) |
| Female | 23 (25.27) | |
| Number of lesions | ≤ 2 | 83 (91.21) |
| > 2 | 8 (8.79) | |
| Maximum diameter of lesions (mm) | Hepatitis A | 26.27 ± 13.80 |
| Hepatitis virus history | Hepatitis B | 71 (78.02) |
| Hepatitis C | 8 (8.79) | |
| No | 12 (13.19) | |
| Artificial ascites | Yes | 25 (27.47) |
| No | 66 (72.53) | |
| Ascites | Yes | 9 (9.89) |
| No | 82 (90.11) | |
| Child-Pugh grade | A | 90 (98.90) |
| B | 1 (1.10) |
- Citation: Pang L, Tang D, Zhou WL, Bai X, Zhao HJ, Wang LQ, Cheng W, Wu BL. Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation. World J Hepatol 2026; 18(1): 113429
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113429.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113429